Risk, returns & timeframes illustration
1 min read
August 3, 2022
by

The health care revolution

Can a sticking plaster fix the US health care sector? Seems Amazon’s bold proposal to triage one of 2020’s fallen IPOs has injected a confidence boost for investors. Even Cathie’s ARK has rallied this June with genomics and health tech providing hope for an industry that’s been on life support.
Risk, returns & timeframes illustration
1 min read
August 3, 2022
by

The health care revolution

Can a sticking plaster fix the US health care sector? Seems Amazon’s bold proposal to triage one of 2020’s fallen IPOs has injected a confidence boost for investors. Even Cathie’s ARK has rallied this June with genomics and health tech providing hope for an industry that’s been on life support.
Table of contents
Free Getting Started Course
Take your first, or next, step to becoming a confident investor with Hatch's free online course – just 10 minutes a day, for 10 days.
Weekly news from Wall St
Subscribe to The Fry Up - your weekly sizzle of headline-grabbing share market news. Read by 60,000 Kiwis to help them take charge of their investing journey.

As Dr Ashley Bloomfield swaps being pulse of the nation for luxury robes and erotic fanfiction, seems Redditers agree on something; shopping may be our collective addiction. And Amazon’s (AMZN) not mad about it. 🛒 The tech giant and shopping mecca last week surpassed even analysts’ ‘rosy’ expectations. This despite a turbulent year that included a 20-for-1 stock split and new CEO Andy Jassy’s first year on the tools. But could it be Amazon’s own add-to-cart moment that’s caught investors attention?  

Since announcing Amazon’s proposed purchase of app-based primary care provider One Medical (ONEM) for US$3.9 billion in an all-cash deal this July, both companies' share prices have lifted. While the deal’s being triaged behind screens, the Amazon Health Services team has hinted at defibrillating the US’s endemic health delays, with health care ‘high on the list of experiences that need reinvention’. More rural MRIs ahead, perhaps? 👨‍⚕️ 

So is Teladoc Health (TDOC) reaching for the laughing gas? Following another disappointing earnings quarter, and having slumped 87.5% from their February 2021 high, Amazon’s proposed cash injection in the health sector may have hearts racing. 🩺 Yet despite Teladoc’s plummet stinging, ARK doesn’t plan to amputate the largest US virtual healthcare provider from their Genomic Revolution ETF (ARKG). And Cathie Wood continues to back problem-solving innovation in the ‘genomic age’. 🧬

While the ETF hasn’t had investors in stitches, falling 56.32% since August last year, it rallied this June thanks to top contributors, biochemical analysis tech company 908 Devices (MASS) and gene-editing companies Crispr Therapeutics (CRSP) and Vertex Pharmaceuticals (VRTX) - which this year secured ‘renowned’ Harvard stem cell researcher Doug Melton to head up type 1 diabetes research. 🌡️ Only time will tell if they’re enough to cure the dis-ease.

We’re not financial advisors and Hatch news is for your information only. However dazzling our writing, none of it is a recommendation to invest in any of the companies or funds mentioned. If you want support before making any investment decisions, consider seeking financial advice from a licensed provider. We’ve done our best to ensure all information is current when we pushed ‘publish’ on this article. And of course, with investing, your money isn’t guaranteed to grow and there’s always a risk you might lose money.

Join the Kiwis who are hatching their tomorrow and have invested more than $1 billion with Hatch.

More recent news articles

More recent learn articles

6 min read
Nov 28, 2023

Black Friday’s record-breaking US$9.8 billion US online sales, US$70.9 billion globally

New Zealand imported Black Friday from the US, but that doesn’t mean we’re spending up large during tighter economic times. While Black Friday spending soared in the US, it seems Kiwis weren’t quite so keen to part with their hard-earned cash. So who was spending up large in record US Black Friday shopping?
Read more
6 min read
Nov 21, 2023

Underrated Thanksgiving stocks and hopes for a seasonal market rally

While 2023 may have felt like a bumpy ride for investors it seems that recession predictions were stymied by a buoyant American economy. Could the road ahead bring in fresh optimism echoing rallies of holidays past?
Read more
5 min read
Nov 14, 2023

Affirm shares surged 24% ahead of holidays splurge

In a world of instant gratification, is buy now pay later (BNPL) just what we do now? While BNPL providers aren't rapidly bringing on more customers and people aren’t using BNPL more, shoppers are missing more payments sinking into a debt cycle helping providers’ revenue to climb. Is this why Affirm’s stock has soared 153% this year?
Read more

More recent news articles

More recent learn articles

6 min read
Nov 28, 2023

Black Friday’s record-breaking US$9.8 billion US online sales, US$70.9 billion globally

New Zealand imported Black Friday from the US, but that doesn’t mean we’re spending up large during tighter economic times. While Black Friday spending soared in the US, it seems Kiwis weren’t quite so keen to part with their hard-earned cash. So who was spending up large in record US Black Friday shopping?
Read more
6 min read
Nov 21, 2023

Underrated Thanksgiving stocks and hopes for a seasonal market rally

While 2023 may have felt like a bumpy ride for investors it seems that recession predictions were stymied by a buoyant American economy. Could the road ahead bring in fresh optimism echoing rallies of holidays past?
Read more
5 min read
Nov 14, 2023

Affirm shares surged 24% ahead of holidays splurge

In a world of instant gratification, is buy now pay later (BNPL) just what we do now? While BNPL providers aren't rapidly bringing on more customers and people aren’t using BNPL more, shoppers are missing more payments sinking into a debt cycle helping providers’ revenue to climb. Is this why Affirm’s stock has soared 153% this year?
Read more